Stay updated on Nivolumab for Squamous Dysplasia Reversal Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for Squamous Dysplasia Reversal Clinical Trial page.

Latest updates to the Nivolumab for Squamous Dysplasia Reversal Clinical Trial page
- Check7 days agoChange DetectedAdded a Locations section highlighting Colorado as a study site; removed the old Colorado Locations entry and the HHS Vulnerability Disclosure, and updated the site revision to v3.3.3.SummaryDifference0.2%

- Check14 days agoChange DetectedResults-related updates were added to the study page, including a posting on 2025-12-12 and milestones for outcomes such as Endobronchial Histology and irAEs, plus links to the protocol document and revised enrollment/completion dates.SummaryDifference2%

- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedRevision: v3.3.2 added; previous revision v3.2.0 removed.SummaryDifference0.1%

- Check43 days agoChange DetectedThe government funding and operating status notice was removed from the page. The study details content remains unchanged.SummaryDifference0.4%

- Check57 days agoChange DetectedMinor formatting and textual tweaks were observed, with no changes to core study details, eligibility criteria, endpoints, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check86 days agoChange DetectedMajor update: new operating-status notice and a version bump to v3.2.0, replacing the old v3.0.2.SummaryDifference3%

Stay in the know with updates to Nivolumab for Squamous Dysplasia Reversal Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for Squamous Dysplasia Reversal Clinical Trial page.